These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 10603616)

  • 21. Autoimmune versus oligodendrogliopathy: the pathogenesis of multiple sclerosis.
    Nakahara J; Aiso S; Suzuki N
    Arch Immunol Ther Exp (Warsz); 2010 Oct; 58(5):325-33. PubMed ID: 20676785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune-mediated oligodendrocyte injury in multiple sclerosis: molecular mechanisms and therapeutic interventions.
    Buntinx M; Stinissen P; Steels P; Ameloot M; Raus J
    Crit Rev Immunol; 2002; 22(5-6):391-424. PubMed ID: 12803318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The enigma of multiple sclerosis: inflammation and neurodegeneration cause heterogeneous dysfunction and damage.
    Owens T
    Curr Opin Neurol; 2003 Jun; 16(3):259-65. PubMed ID: 12858060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Axonal damage and its significance for the concept of neurodegeneration in multiple sclerosis].
    Recks MS; Bader J; Kaiser CC; Schroeter M; Fink GR; Addicks K; Kuerten S
    Fortschr Neurol Psychiatr; 2011 Mar; 79(3):161-70. PubMed ID: 21394707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Axonal problems in demyelinating pathologies: role of inflammation and demyelinization].
    Lubetzki C
    Rev Neurol (Paris); 2009 Apr; 165 Spec No 2():F109-13. PubMed ID: 19593876
    [No Abstract]   [Full Text] [Related]  

  • 26. [The pathogenesis of multiple sclerosis].
    Kesselring J
    Schweiz Med Wochenschr; 1990 Jul; 120(30):1083-90. PubMed ID: 2203139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pathology of multiple sclerosis.
    Sobel RA
    Neurol Clin; 1995 Feb; 13(1):1-21. PubMed ID: 7739499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple sclerosis as a neurodegenerative disease: pathology, mechanisms and therapeutic implications.
    Stadelmann C
    Curr Opin Neurol; 2011 Jun; 24(3):224-9. PubMed ID: 21455066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitochondrial changes associated with demyelination: consequences for axonal integrity.
    Campbell GR; Mahad DJ
    Mitochondrion; 2012 Mar; 12(2):173-9. PubMed ID: 21406249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Neuronal injury in multiple sclerosis].
    Correale J; Meli F; Ysrraelit C
    Medicina (B Aires); 2006; 66(5):472-85. PubMed ID: 17137182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuropathology in multiple sclerosis: new concepts.
    Lassmann H
    Mult Scler; 1998 Jun; 4(3):93-8. PubMed ID: 9762654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunologic aspects of multiple sclerosis.
    Boppana S; Huang H; Ito K; Dhib-Jalbut S
    Mt Sinai J Med; 2011; 78(2):207-20. PubMed ID: 21425265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Perspectives in multiple sclerosis research].
    Lassmann H
    Wien Med Wochenschr; 1996; 146(19-20):528-32. PubMed ID: 9082653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Astrocyte-associated axonal damage in pre-onset stages of experimental autoimmune encephalomyelitis.
    Wang D; Ayers MM; Catmull DV; Hazelwood LJ; Bernard CC; Orian JM
    Glia; 2005 Aug; 51(3):235-40. PubMed ID: 15812814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compartmentalization of inflammation in the CNS: a major mechanism driving progressive multiple sclerosis.
    Meinl E; Krumbholz M; Derfuss T; Junker A; Hohlfeld R
    J Neurol Sci; 2008 Nov; 274(1-2):42-4. PubMed ID: 18715571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental demyelination caused by primary oligodendrocyte dystrophy. Regional distribution of the lesions in the nervous system of mice [corrected].
    Komoly S
    Ideggyogy Sz; 2005 Jan; 58(1-2):40-3. PubMed ID: 15884397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The immunology of multiple sclerosis: disease mechanisms and therapeutic targets.
    Holmøy T
    Minerva Med; 2008 Apr; 99(2):119-40. PubMed ID: 18431322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of axon-glial injury of the optic nerve.
    Compston A
    Eye (Lond); 2004 Nov; 18(11):1182-7. PubMed ID: 15534604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterogeneity of pathogenesis in multiple sclerosis: implications for promotion of remyelination.
    Paz Soldan MM; Rodriguez M
    J Infect Dis; 2002 Dec; 186 Suppl 2():S248-53. PubMed ID: 12424705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Some aspects of histopathology in multiple sclerosis].
    Kuhlmann T; Brück W
    Rev Neurol; 2000 Jun 16-30; 30(12):1208-12. PubMed ID: 10935252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.